ArticlePsychopharmacology2019

Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.

Adam L Halberstadt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.